Cargando…
P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430504/ http://dx.doi.org/10.1097/01.HS9.0000971964.73633.04 |
| _version_ | 1785090979840131072 |
|---|---|
| author | Mata, Jonaphine Rosen, Natalie S. Zahurak, Marianna Jones, Richard Ambinder, Alex |
| author_facet | Mata, Jonaphine Rosen, Natalie S. Zahurak, Marianna Jones, Richard Ambinder, Alex |
| author_sort | Mata, Jonaphine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430504 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104305042023-08-17 P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE Mata, Jonaphine Rosen, Natalie S. Zahurak, Marianna Jones, Richard Ambinder, Alex Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430504/ http://dx.doi.org/10.1097/01.HS9.0000971964.73633.04 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Mata, Jonaphine Rosen, Natalie S. Zahurak, Marianna Jones, Richard Ambinder, Alex P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title | P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_full | P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_fullStr | P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_full_unstemmed | P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_short | P1269: PRIMARY GRAFT FAILURE INCIDENCE, RISK FACTORS, AND OUTCOMES IN PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_sort | p1269: primary graft failure incidence, risk factors, and outcomes in patients undergoing non-myeloablative allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430504/ http://dx.doi.org/10.1097/01.HS9.0000971964.73633.04 |
| work_keys_str_mv | AT matajonaphine p1269primarygraftfailureincidenceriskfactorsandoutcomesinpatientsundergoingnonmyeloablativeallogeneichematopoieticcelltransplantationusingposttransplantcyclophosphamide AT rosennatalies p1269primarygraftfailureincidenceriskfactorsandoutcomesinpatientsundergoingnonmyeloablativeallogeneichematopoieticcelltransplantationusingposttransplantcyclophosphamide AT zahurakmarianna p1269primarygraftfailureincidenceriskfactorsandoutcomesinpatientsundergoingnonmyeloablativeallogeneichematopoieticcelltransplantationusingposttransplantcyclophosphamide AT jonesrichard p1269primarygraftfailureincidenceriskfactorsandoutcomesinpatientsundergoingnonmyeloablativeallogeneichematopoieticcelltransplantationusingposttransplantcyclophosphamide AT ambinderalex p1269primarygraftfailureincidenceriskfactorsandoutcomesinpatientsundergoingnonmyeloablativeallogeneichematopoieticcelltransplantationusingposttransplantcyclophosphamide |